← All Genmab A/s filings

Genmab A/s Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
GMAB
Genmab A/s
SCHEDULE: Genmab Completes Merus N.V. Acquisition, Delisting Shares
Genmab A/S has successfully completed its tender offer and subsequent merger to acquire all outstanding shares of Merus N.V. for $97.00 per share, leading to its delisting from Nasdaq.
NASDAQ
GMAB
Genmab A/s
SCHEDULE: Genmab Secures 94.8% Stake in Merus N.V. Tender Offer
Genmab A/S has successfully acquired 94.8% of Merus N.V. common shares through a tender offer at $97.00 per share, moving towards full control and delisting.